These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15248318)

  • 1. A self-perpetuating treatment: humatrope and the medicalization of social problems.
    Feldberg R
    Genewatch; 2004; 17(2):12-3. PubMed ID: 15248318
    [No Abstract]   [Full Text] [Related]  

  • 2. The short of it: more short children are being given growth hormone in the hope that an extra inch will protect their supposedly fragile psyches. But research suggests that their height is a problem less for them than for us.
    Hall SS
    N Y Times Mag; 2005 Oct; ():54-9. PubMed ID: 16733876
    [No Abstract]   [Full Text] [Related]  

  • 3. Human growth hormone and the temptations of biomedical enhancement.
    Conrad P; Potter D
    Sociol Health Illn; 2004 Mar; 26(2):184-215. PubMed ID: 15027984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human growth hormone and the measure of man.
    Fox D
    New Atlantis; 2004 Fall-2005 Winter; 7():75-87. PubMed ID: 15812949
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethics for the pediatrician: the persuasion of enhancements in pediatrics.
    Yates FD
    Pediatr Rev; 2010 May; 31(5):216-8. PubMed ID: 20435714
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized, double-blind study to assess the efficacy and safety of valtropin, a biosimilar growth hormone, in children with growth hormone deficiency.
    Peterkova V; Arslanoglu I; Bolshova-Zubkovskaya E; Romer T; Zdravkovic D; Kratzsch J; Ji HJ; Savoy C; Saenger P
    Horm Res; 2007; 68(6):288-93. PubMed ID: 17627092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic breakthroughs and the limits of medicine: short stature, growth hormone, and the idea of dysfunction.
    Schwartz PH
    St Thomas Law Rev; 2001; 13(4):965-78. PubMed ID: 12661585
    [No Abstract]   [Full Text] [Related]  

  • 8. Pressuring insurers to pay for medically unnecessary treatments.
    Chapin G
    Manag Care Interface; 2003 Dec; 16(12):19-20. PubMed ID: 14750458
    [No Abstract]   [Full Text] [Related]  

  • 9. The bioengineered competitor? Steroids, hormones, and individual rights.
    Murray TH
    Natl Forum; 1989; 69(4):41-2. PubMed ID: 16100839
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimizing growth hormone therapy in growth hormone deficient children: what to do in the absence of hard evidence? Commentary on Rachmiel et al.: Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone (Horm Res 2007;68:236-243).
    Wit JM
    Horm Res; 2007; 68(5):244-7. PubMed ID: 17396035
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in pediatric growth hormone therapy: IGF-I-based dosing.
    Pawlikowska-Haddal A; Cohen P
    Indian Pediatr; 2006 Jul; 43(7):577-81. PubMed ID: 16891676
    [No Abstract]   [Full Text] [Related]  

  • 12. [The model of height prognosis in children with growth hormone deficiency].
    Kostecka L; Wasikowa R; Noczyńska A; Filipowski H
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):113-7. PubMed ID: 15504314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tale of two centimeters.
    Rosenfeld RG
    J Pediatr; 2005 Jan; 146(1):10-1. PubMed ID: 15644813
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethics for the pediatrician: a brave new pediatrics? Managing the desire for better children through biotechnological enhancement.
    Antiel RM; Jacobson RM; Fischer PR
    Pediatr Rev; 2012 Feb; 33(2):e13-7. PubMed ID: 22301037
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth hormone therapy for short children born small for gestational age.
    Chatelain P; Carrascosa A; Bona G; Ferrandez-Longas A; Sippell W
    Horm Res; 2007; 68(6):300-9. PubMed ID: 17823537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
    Bajpai A; Kabra M; Gupta AK; Menon PS
    Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal use of growth hormone therapy for maximizing adult height in children born small for gestational age.
    Simon D; Léger J; Carel JC
    Best Pract Res Clin Endocrinol Metab; 2008 Jun; 22(3):525-37. PubMed ID: 18538291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC; Lindberg A
    Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone.
    Mul D; Oostdijk W; Waelkens JJ; Drop SL
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):185-90. PubMed ID: 16060912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
    Rachmiel M; Rota V; Atenafu E; Daneman D; Hamilton J
    Horm Res; 2007; 68(5):236-43. PubMed ID: 17396034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.